InMed Pharmaceuticals (INM) Prepaid Assets (2020 - 2026)
InMed Pharmaceuticals (INM) reported Prepaid Assets of $617211.0 for Q1 2026, up 21.53% on a YoY basis from $507872.0 in Q1 2025, and down 6.52% quarter-over-quarter from $660280.0 in Q4 2025.
InMed Pharmaceuticals (INM) Prepaid Assets (2020 - 2026) Analysis & Trends
InMed Pharmaceuticals has reported Prepaid Assets for 7 years, with the latest figure at $617211.0 in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets rose 21.53% year-over-year to $617211.0; the trailing twelve-month figure through Mar 2026 stood at $617211.0 (up 21.53% YoY), and the FY2025 full-year result was $319547.0, down 33.11% from the prior year.
- Prepaid Assets for Q1 2026 stood at $617211.0, down from $660280.0 in the prior quarter.
- The five-year high for Prepaid Assets was $1.3 million in Q1 2022, with the low at $148882.0 in Q3 2024.
- Historically, Prepaid Assets has averaged $611738.6 across 5 years, with a median of $617211.0 in 2026.
- Annual changes were most pronounced in 2022 — Prepaid Assets surged 488.51% — and 2025, when it sank 50.14%.
- InMed Pharmaceuticals' Prepaid Assets stood at $826931.0 in 2022, then jumped by 34.59% to $1.1 million in 2023, then plunged by 42.14% to $643986.0 in 2024, then rose by 2.53% to $660280.0 in 2025, then slipped by 6.52% to $617211.0 in 2026.
- The last three Prepaid Assets figures came in at $617211.0 (Q1 2026), $660280.0 (Q4 2025), and $191755.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | InMed Pharmaceuticals | 6.04 Mn | 796,124.14 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 617,211.00 |
| Dec 31, 2025 | 660,280.00 |
| Sep 30, 2025 | 191,755.00 |
| Jun 30, 2025 | 319,547.00 |
| Mar 31, 2025 | 507,872.00 |
| Dec 31, 2024 | 643,986.00 |
| Sep 30, 2024 | 148,882.00 |
| Jun 30, 2024 | 477,749.00 |
| Mar 31, 2024 | 1.02 Mn |
| Dec 31, 2023 | 1.11 Mn |
| Sep 30, 2023 | 215,015.00 |
| Jun 30, 2023 | 498,033.00 |
| Mar 31, 2023 | 695,203.00 |
| Dec 31, 2022 | 826,931.00 |
| Sep 30, 2022 | 356,665.00 |
| Jun 30, 2022 | 797,225.00 |
| Mar 31, 2022 | 1.31 Mn |
| Dec 31, 2021 | 140,512.00 |
| Sep 30, 2021 | 322,352.00 |
| Jun 30, 2021 | 956,762.00 |